Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 30, Number 9—September 2024
Dispatch

Retrospective Seroprevalence of Orthopoxvirus Antibodies among Key Populations, Kenya

Kristi Loeb1, Kieran A. Milner1, Candice Lemaille, Brielle Martens, Derek Stein, Julie Lajoie, Souradet Y. Shaw, Anne W. Rimoin, Placide Mbala-Kingebeni, Nicole A. Hoff, Ryan S. Noyce, Keith R. Fowke, Joshua Kimani, Lyle McKinnon, and Jason KindrachukComments to Author 
Author affiliations: University of Manitoba, Winnipeg, Manitoba, Canada (K. Loeb, K.A. Milner, C. Lemaille, B. Martens, D. Stein, J. Lajoie, S.Y. Shaw, K.R. Fowke, J. Kimani, L. McKinnon, J. Kindrachuk); Cadham Provincial Laboratory, Winnipeg (D. Stein); University of Nairobi, Nairobi, Kenya (J. Lajoie, K.R. Fowke, J. Kimani, L. McKinnon); University of California–Los Angeles, Los Angeles, California, USA (N.A. Hoff, A.W. Rimoin); Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo (P. Mbala-Kingebeni); University of Alberta, Edmonton, Alberta, Canada (R.S. Noyce)

Main Article

Table

Demographic data for all participants in a retrospective study of seroprevalence of orthopoxvirus antibodies among key populations, Nairobi, Kenya, 2013–2018*

Characteristic Human orthopoxvirus seropositivity
 Total (%)
Y N
Age group, y
<19 0 1 (0.2) 1 (0.2)
20–39 37 (37.4) 188 (33.8) 225 (34.3)
40–55 36 (36.4) 242 (43.4) 278 (42.4)
56–65 8 (8.1) 60 (10.8) 68 (10.4)
>65 2 (2.0) 5 (0.9) 7 (1.1)
Unknown 16 (16.2) 61 (11.0) 77 (11.7)
Total 99 557 656
Sample collection year
2013 1 (1.0) 7 (1.3) 8 (1.2)
2014 5 (5.1) 55 (9.9) 60 (9.1)
2015 3 (3.0) 15 (2.7) 18 (2.7)
2016 3 (3.0) 13 (2.3) 16 (2.4)
2017 61 (61.6) 277 (49.7) 338 (51.5)
2018 26 (26.3) 190 (34.1) 216 (32.9)
Total 99 557 656
HIV status
Negative 11 (11.1) 82 (14.7) 93 (14.2)
Positive 88 (88.9) 475 (85.3) 563 (85.8)
Total 99 557 656
Key population
Female sex worker 63 (63.6) 411 (73.8) 474 (72.3)
GBMSM 15 (15.2) 46 (8.3) 61 (9.3)
Non–sex worker 21 (21.2) 100 (17.9) 121 (18.4)
Total 99 557 656

*Participants were enrolled at the Sex Workers Outreach Program (SWOP) in Nairobi, Kenya. Values are no. (%). Seropositivity determined by ELISA using UV-inactivated vaccinia virus. GBMSM, gay, bisexual, and other men who have sex with men.

Main Article

1These first authors contributed equally to this article.

Page created: July 30, 2024
Page updated: August 09, 2024
Page reviewed: August 09, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external